We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App

AI Vital For Rapid Identification of Drugs That Can Be Repurposed To Combat COVID-19, Says New Report

By HospiMedica International staff writers
Posted on 21 Aug 2020
Print article
Artificial intelligence (AI) offers significant promise for biopharmaceutical companies to speed up the drug repurposing process for finding new therapies to treat COVID-19, according to a new report.

The COVID-19 Executive Briefing report by GlobalData (London, UK; www.globaldata.com), a research, consulting and events firm, states that drug repurposing is among the fastest and safest methods to seek new therapies for the treatment of COVID-19, as the drugs are already being used for treating various existing conditions, thus reducing the possibility of adverse reactions. AI technologies are expected to play a significant role in allowing biopharmaceutical companies to shorten the time required for pre-clinical drug identification and design process.

The Innovation Explorer database of GlobalData’s Disruptor Intelligence Center has revealed how AI startups are helping identify suitable molecules that target COVID-19. For instance, BenevolentAI, a startup, is using its AI-based drug discovery platform to identify drugs that have the potential to disrupt selected viral entry pathways of COVID-19, thereby preventing the virus from replicating. Another startup Elix has harnessed various neural networks in order to predict the chemical properties of molecules with the capacity to neutralize COVID-19. Similarly, Gero, a startup, has leveraged AI to rapidly screen existing drug molecules for the treatment of COVID-19. Additionally, other startups such as Repurpose.AI and Atomwise are entering into partnerships with global research institutes to utilize their AI-powered predictive models for locating new drug molecules for the treatment of COVID-19.

“Typically developing a new drug takes almost a decade and costs anywhere between $2 billion to USD 3 billion,” said Venkata Naveen, Senior Disruptive Tech Analyst at GlobalData. “But now biopharmaceutical companies are in dire need to accelerate the entire drug development process given that COVID-19 cases and deaths are mounting every day. Under these circumstances, AI technologies allow companies to significantly shorten the pre-clinical drug identification and design process from several years to a few days or months.”

Related Links:


Print article


Surgical Techniques

view channel
Image: Persona IQ is a first-to-world smart implant that captures key kinematic data metrics (Photo courtesy of Zimmer Biomet)

World’s First Smart Knee Implant Optimizes Patient Monitoring and Recovery After Surgery

A first-to-world smart knee implant utilizes sensor-based technology to allow physicians and care teams to collect patient-specific kinematic data during the course of patient monitoring.... Read more

Patient Care

view channel
Image: The biomolecular film can be picked up with tweezers and placed onto a wound (Photo courtesy of TUM)

Biomolecular Wound Healing Film Adheres to Sensitive Tissue and Releases Active Ingredients

Conventional bandages may be very effective for treating smaller skin abrasions, but things get more difficult when it comes to soft-tissue injuries such as on the tongue or on sensitive surfaces like... Read more

Health IT

view channel
Image: AI can reveal a patient`s heart health (Photo courtesy of Mayo Clinic)

AI Trained for Specific Vocal Biomarkers Could Accurately Predict Coronary Artery Disease

Earlier studies have examined the use of voice analysis for identifying voice markers associated with coronary artery disease (CAD) and heart failure. Other research groups have explored the use of similar... Read more


view channel
Image: The global capsule endoscopy system market is growing at a rapid pace (Photo courtesy of Pexels)

Capsule Endoscopy System Market Driven by Rising Preference for Minimally Invasive Screening Procedure

Capsule endoscopy is generally a non-invasive technique that enables complete examination of the gastrointestinal tract with the use of the disposable and wireless device known as the video capsule.... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.